Understanding CD56 Expression in Multiple Myeloma: Clinical Implications and  Prognostic Value

Ayman Fathy Abd El Halim , Abdullah Mohammad Abd-Elhameed ,Ahmed Mohamed Ibrahim Hassan,  Shaimaa Abd-Elmonem Mohammed

Understanding CD56 Expression in Multiple Myeloma: Clinical Implications and Prognostic Value

Authors

Ayman Fathy Abd El Halim , Abdullah Mohammad Abd-Elhameed ,Ahmed Mohamed Ibrahim Hassan, Shaimaa Abd-Elmonem Mohammed

Keywords:

CD56 Expression , Multiple Myeloma, Prognosis

Abstract

Multiple myeloma (MM) is a hematologic malignancy characterized by the uncontrolled proliferation of clonal plasma
cells within the bone marrow. CD56

References

Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification, and management. Am J Hematol.

;95(5):548-567.

Kazandjian D. Multiple myeloma epidemiology and survival: A unique malignancy. Semin Oncol.

;43(6):676-681.

Downloads

Published

2024-06-20

How to Cite

Ayman Fathy Abd El Halim , Abdullah Mohammad Abd-Elhameed ,Ahmed Mohamed Ibrahim Hassan, Shaimaa Abd-Elmonem Mohammed. (2024). Understanding CD56 Expression in Multiple Myeloma: Clinical Implications and Prognostic Value . Journal of Computational Analysis and Applications (JoCAAA), 33(06), 2143–2153. Retrieved from https://www.eudoxuspress.com/index.php/pub/article/view/3013